Treatment | 3 months | 6 months | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CR | PR | SD | PD | OR | DC | CR | PR | SD | PD | OR | DC | |
DEB-TACE (n = 24) | 6 (25.0%) | 14 (58.3%) | 2 (8.3%) | 2 (8.3%) | 20 (83.3%) | 22 (91.7%) | 5 (20.8%) | 10 (41.7%) | 5 (20.8%) | 4 (16.7%) | 15 (62.5%) | 20 (83.3%) |
cTACE (n = 30) | 1 (3.3%) | 12 (40.0%) | 7 (23.3%) | 10 (33.3%) | 13 (43.3%) | 20 (66.7%) | 0 | 9 (30.0%) | 8 (26.7%) | 13 (43.3%) | 9 (30.0%) | 17 (56.7%) |
χ2 value | 5.548 | 1.795 | 2.160 | 4.821 | 8.977 | 4.821 | 6.888 | 0.796 | 0.248 | 4.396 | 5.704 | 4.396 |
p value | 0.019 | 0.180 | 0.142 | 0.028 | 0.003 | 0.028 | 0.009 | 0.372 | 0.618 | 0.036 | 0.017 | 0.036 |